ADVERTISEMENT
Wound Debridement 2024 Outlook
This blog was originally posted on SmartTrak's website on February 12, 2024: https://blog.smarttrak.com/wound-debridement-2024-outlook?hs_preview=YAxvPbdM-156497389937. Reposted with permission.
With the eyes of the wound care world focused on the markets for Skin Substitutes and Antimicrobials, SmartTRAK discusses how 2024 could be a disruptive year for Debridement.
SmartTRAK forecasts that the WW Debridement Market will grow at a 5-year CAGR of +4.9% to 2027E, at which point it will be valued at over half a billion dollars. In this article, Kris Flinn, SmartTRAK's Sr. Analyst, Wound, does a deep dive into what's ahead for the debridement market, including the indexed growth for Advanced Wound Care (AWC) and Debridement for each of the three SmartTRAK geographical regions: US, Europe (EU) and the Rest of World (ROW).
Among the topics covered in detail in this market outlook article, which can be downloaded here, are:
- Chemical Debridement Growing Pains
Chemical Debridement is the smallest of the Debridement segments The WW 5-year CAGR of +69.1% promises a brighter future, with usage growing across all geographic regions, including ... - New Enzymatic Debridement Technologies Continue to Build Evidence
MediWound presented Phase IIB clinical trial results for bromelain-based EscharEx at the SAWC Spring meeting in May 2023. The 120-patient venous leg ulcer, multicenter, randomized control trial compared EscharEx with a placebo gel vehicle and a non-surgical standard of care (SoC). Results showed... - Burn Market to Fire Up
In addition to focusing on the chronic wound market with EscharEx, MediWound is also looking to grow in the burn market with its product NexoBrid. The Company received FDA approval for its... - Portfolio Completion
SmartTRAK believes that 2024 will see more AWC companies enhancing their portfolios with wound cleansers/irrigation solutions and mechanical debridement products.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
